Date:28-Apr-2024  Time: 1:37 AM
 
 
        
Glenmark Pharmaceuticals Ltd
(Rs. In Crores)
YearsMar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
Debt-Equity Ratio0.200.240.260.270.270.29
Long Term Debt-Equity Ratio0.150.180.220.240.250.27
Current Ratio1.481.802.122.212.522.87
Fixed Assets2.652.772.782.772.602.24
Inventory8.059.509.467.686.244.91
Debtors3.173.153.503.422.131.44
Interest Cover Ratio10.979.088.316.998.186.99
PBIDTM (%)29.8428.2931.1928.7530.7225.78
PBITM (%)27.6026.3329.2026.6829.0424.05
PBDTM (%)27.3225.4027.6824.9327.1822.34
CPM (%)21.4422.1523.7922.2423.0220.03
APATM (%)19.2020.1921.8020.1821.3318.30
ROCE (%)10.7910.9312.3911.1312.8310.42
RONW (%)9.1210.4211.7710.7612.0410.23
 
Source:Capital Market
 
Useful linksNSEIBSEI SEBIINSDLI NCDEXI CDSLIRBI      Careers | Feedback | Sitemap | Disclaimer | Privacy Policy | Grievances
Sebi Reg No: NSE INB231168734(CM) INF231168734(F&O) Sebi Reg No: BSE INB011168730 INF011168730   NCDEX: Membership Code: 00774
MCX: Membership Code: 31560  Mutual Funds: ARN0843.
FMC Unique Membership Code: MCX/TCM/CORP/1106
2006-07 © Senator Securities Pvt. Ltd. All rights reserved
FMC Unique Membership Code: NCDEX/TCM/CORP/0760
Design, developed & maintained by C-MOTS Infotech(ISO 9001:2000 certified)
Content powered by capitalmarket.com